Instadose Pharma Valuation

INSD Stock  USD 0.0001  0.00  0.00%   
Instadose Pharma seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Instadose Pharma Corp from evaluating the firm fundamentals such as Price To Book of 0.02 X, return on asset of -694.06, and Current Valuation of 757.11 K as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Instadose Pharma's valuation include:
Price Book
0.0221
Enterprise Value
757.1 K
Enterprise Value Ebitda
(1.28)
Overvalued
Today
0.0001
Please note that Instadose Pharma's price fluctuation is very steady at this time. Calculation of the real value of Instadose Pharma Corp is based on 3 months time horizon. Increasing Instadose Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Instadose stock is determined by what a typical buyer is willing to pay for full or partial control of Instadose Pharma Corp. Since Instadose Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Instadose Stock. However, Instadose Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.0E-4 Real  8.4E-5 Hype  1.0E-4
The real value of Instadose Stock, also known as its intrinsic value, is the underlying worth of Instadose Pharma Corp Company, which is reflected in its stock price. It is based on Instadose Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Instadose Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.000084
Real Value
0.00
Upside
Estimating the potential upside or downside of Instadose Pharma Corp helps investors to forecast how Instadose stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Instadose Pharma more accurately as focusing exclusively on Instadose Pharma's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Instadose Pharma's intrinsic value based on its ongoing forecasts of Instadose Pharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Instadose Pharma's closest peers. If more than one evaluation category is relevant for Instadose Pharma we suggest using both methods to arrive at a better estimate.

Instadose Pharma Cash

65.0

Instadose Valuation Drivers Correlation

Many accounts on the financial statements of Instadose Pharma Corp are highly interrelated and sometimes correlated. Consequently, when conducting Instadose's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Instadose
Click cells to compare fundamentals

About Instadose Pharma Valuation

The stock valuation mechanism determines Instadose Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Instadose Pharma. We calculate exposure to Instadose Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Instadose Pharma's related companies.
Last ReportedProjected for Next Year
Pretax Profit Margin(7.80)(8.19)
Operating Profit Margin(5.88)(6.17)
Net Loss(7.80)(8.19)
Gross Profit Margin 0.44  0.39 

Instadose Pharma Growth Indicators

Investing in growth stocks can be very risky. If the company such as Instadose Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding75 M
Shares Float402 M

Instadose Pharma Current Valuation Indicators

Valuation refers to the process of determining the present value of Instadose Pharma Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Instadose we look at many different elements of the entity such as Instadose's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Instadose Pharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Instadose Pharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Instadose Pharma's worth.

Complementary Tools for Instadose Stock analysis

When running Instadose Pharma's price analysis, check to measure Instadose Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Instadose Pharma is operating at the current time. Most of Instadose Pharma's value examination focuses on studying past and present price action to predict the probability of Instadose Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Instadose Pharma's price. Additionally, you may evaluate how the addition of Instadose Pharma to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated